Treatment of XXXX with renal infarction, delayed nephrectomy, medroxyprogesterone, and xenogeneic immune RNA.

@entity1 @entity742 @entity5 @entity1358 @entity3
The authors have used xenogeneic immune ribonucleic acid (RNA) in the treatment of @entity1 with @entity1358 . This has been used in conjunction with renal artery embolization, delayed nephrectomy, and progestational therapy, using immune RNA derived from @entity742 cell lymphocytes immunized with @entity1 's @entity5 . Four of 5 @entity1 with Stage I disease had extremely large @entity5 . This group is alive with no evidence of disease at twelve to twenty-four months. There are no Stage II @entity5 in this group. One @entity1 with @entity5 is alive at twenty-two months without evidence of disease. Three @entity1 with @entity3 are stable at five to twenty-two months. Two @entity1 have progressive disease at three and six months. This treatment has not been effective in @entity1 with massive @entity5 burden. The results in the other groups are encouraging.
